Christopher Jewell - Insider Trading & Ownership

Entity
Individual
Location
C/O Cartesian Therapeutics, Inc., 704 Quince Orchard Rd, Gaithersburg, MD
Summary
The estimated net worth of Christopher Jewell is at least $514K dollars as of November 18, 2024. Christopher Jewell is the Chief Scientific Officer of Cartesian Therapeutics, Inc. and owns shares of Cartesian Therapeutics, Inc. (RNAC) stock worth about $514K.
All Insider Reports
All Insider Reports

Ownership of Christopher Jewell

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
RNAC Cartesian Therapeutics, Inc. Chief Scientific Officer $514K -$875K -63% Nov 14, 2024

Insider Transactions Reported by Christopher Jewell:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.